JP2013511534A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013511534A5 JP2013511534A5 JP2012540047A JP2012540047A JP2013511534A5 JP 2013511534 A5 JP2013511534 A5 JP 2013511534A5 JP 2012540047 A JP2012540047 A JP 2012540047A JP 2012540047 A JP2012540047 A JP 2012540047A JP 2013511534 A5 JP2013511534 A5 JP 2013511534A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- medicament
- psoriasis
- brimonidine
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 claims 12
- 201000004681 Psoriasis Diseases 0.000 claims 4
- 208000024891 symptom Diseases 0.000 claims 4
- XYLJNLCSTIOKRM-UHFFFAOYSA-N Alphagan Chemical compound C1=CC2=NC=CN=C2C(Br)=C1NC1=NCCN1 XYLJNLCSTIOKRM-UHFFFAOYSA-N 0.000 claims 3
- 229960003679 brimonidine Drugs 0.000 claims 3
- 239000000499 gel Substances 0.000 claims 3
- 239000002674 ointment Substances 0.000 claims 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 239000006071 cream Substances 0.000 claims 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims 1
- 239000004909 Moisturizer Substances 0.000 claims 1
- 229920002125 Sokalan® Polymers 0.000 claims 1
- 235000021355 Stearic acid Nutrition 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 239000000443 aerosol Substances 0.000 claims 1
- 229960001631 carbomer Drugs 0.000 claims 1
- 229960000541 cetyl alcohol Drugs 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000000839 emulsion Substances 0.000 claims 1
- 239000003349 gelling agent Substances 0.000 claims 1
- 235000011187 glycerol Nutrition 0.000 claims 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 claims 1
- 239000003589 local anesthetic agent Substances 0.000 claims 1
- 239000006210 lotion Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- -1 mists Substances 0.000 claims 1
- 230000001333 moisturizer Effects 0.000 claims 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 claims 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims 1
- 239000006072 paste Substances 0.000 claims 1
- 229920000058 polyacrylate Polymers 0.000 claims 1
- 239000003755 preservative agent Substances 0.000 claims 1
- 230000002335 preservative effect Effects 0.000 claims 1
- 239000000243 solution Substances 0.000 claims 1
- 239000007921 spray Substances 0.000 claims 1
- 239000008117 stearic acid Substances 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
- 239000004408 titanium dioxide Substances 0.000 claims 1
- 238000011200 topical administration Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12/621,942 | 2009-11-19 | ||
| US12/621,942 US8394800B2 (en) | 2009-11-19 | 2009-11-19 | Method for treating psoriasis |
| PCT/US2010/057184 WO2011075267A1 (en) | 2009-11-19 | 2010-11-18 | Use of alpha 2 adrenergic receptor agonists for treating or preventing psoriasis |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013511534A JP2013511534A (ja) | 2013-04-04 |
| JP2013511534A5 true JP2013511534A5 (cg-RX-API-DMAC7.html) | 2013-06-27 |
| JP5680660B2 JP5680660B2 (ja) | 2015-03-04 |
Family
ID=43729952
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012540047A Expired - Fee Related JP5680660B2 (ja) | 2009-11-19 | 2010-11-18 | 乾癬を治療または予防するためのα２アドレナリン受容体作動薬の使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US8394800B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2501373B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5680660B2 (cg-RX-API-DMAC7.html) |
| KR (2) | KR20130106439A (cg-RX-API-DMAC7.html) |
| CN (1) | CN102844025B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2010332233C1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112012012131A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2781112C (cg-RX-API-DMAC7.html) |
| ES (1) | ES2532527T3 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2012005790A (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ600333A (cg-RX-API-DMAC7.html) |
| RU (1) | RU2538729C2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2011075267A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8410102B2 (en) * | 2003-05-27 | 2013-04-02 | Galderma Laboratories Inc. | Methods and compositions for treating or preventing erythema |
| US7439241B2 (en) * | 2003-05-27 | 2008-10-21 | Galderma Laboratories, Inc. | Compounds, formulations, and methods for treating or preventing rosacea |
| US8394800B2 (en) | 2009-11-19 | 2013-03-12 | Galderma Laboratories, L.P. | Method for treating psoriasis |
| CA2792649A1 (en) | 2010-03-26 | 2011-09-29 | Michael Graeber | Improved methods and compositions for safe and effective treatment of telangiectasia |
| AU2011231543B2 (en) | 2010-03-26 | 2015-01-15 | Galderma Research & Development | Improved methods and compositions for safe and effective treatment of erythema |
| US8492422B2 (en) * | 2010-09-16 | 2013-07-23 | Allergan, Inc. | Ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for treating skin diseases and conditions |
| US20120076738A1 (en) * | 2010-09-28 | 2012-03-29 | Michael Graeber | Combination treatment for dermatological conditions |
| EP2444068B2 (en) | 2010-10-21 | 2017-12-06 | Galderma S.A. | Brimonidine gel composition |
| US8053427B1 (en) * | 2010-10-21 | 2011-11-08 | Galderma R&D SNC | Brimonidine gel composition |
| FR2977493B1 (fr) * | 2011-07-05 | 2014-02-14 | Galderma Res & Dev | Nouvelle composition anesthesique stable pour la reduction des reactions cutanees |
| WO2013016072A1 (en) * | 2011-07-22 | 2013-01-31 | Allergan, Inc. | Pharmaceutical compositions comprising 4-bromo-n-(imidazolidin-2-ylidene)-1h-benzimidazol-5-amine for treating skin diseases |
| US9283217B2 (en) | 2011-11-10 | 2016-03-15 | Allergan, Inc. | Pharmaceutical compositions comprising 7-(1 H-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions |
| UA109359C2 (xx) * | 2011-11-10 | 2015-08-10 | Лікування захворювань і станів шкіри 7-(1h-імідазол-4-ілметил)-5,6,7,8-тетрагідрохіноліном | |
| US9861645B2 (en) | 2012-12-28 | 2018-01-09 | Rak Holdings Llc | Anti-itch scalp treatment compositions and combinations |
| US20140350106A1 (en) * | 2013-05-22 | 2014-11-27 | Professional Compounding Centers Of America | Urea Silicone Gel for Scars and Hydration Treatment and Method of Using Same |
| KR20160037791A (ko) * | 2014-09-29 | 2016-04-06 | (주)네오팜 | 건성 치료용 산성 외용제 조성물 |
| US20220211672A1 (en) * | 2019-05-01 | 2022-07-07 | Clexio Biosciences Ltd. | Methods of treating pruritus |
| CN113784712A (zh) | 2019-05-01 | 2021-12-10 | 克雷西奥生物科技有限公司 | 治疗瘙痒的方法 |
Family Cites Families (80)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3278447A (en) | 1963-12-02 | 1966-10-11 | Cloro Bac Products Inc | Process for stabilizing chlorine dioxide solution |
| US3560501A (en) | 1966-09-15 | 1971-02-02 | Ciba Geigy Corp | Process for making dihydroquinazolines |
| US3723432A (en) | 1968-11-12 | 1973-03-27 | Sandoz Ag | 1-substituted-4-aryl-2(1h)-quinazolinones and their preparation |
| US3594380A (en) | 1969-02-18 | 1971-07-20 | American Home Prod | Isoquinolin-1(2h)-ones |
| BE766039A (fr) | 1971-04-21 | 1971-09-16 | Labofina Sa | Nouveaux polymeres contenant des unites de pyrazole et procede de preparation de ces polymeres. |
| US3740442A (en) | 1972-01-14 | 1973-06-19 | Sandoz Ag | 2-isopropylaminobenzophenones in treating inflammation |
| US4029792A (en) | 1972-02-29 | 1977-06-14 | Pfizer Inc. | (2-Imidazolin-2-ylamino) substituted -quinoxalines and -quinazolines as antihypertensive agents |
| BE795970A (fr) | 1972-02-29 | 1973-08-27 | Pfizer | Nouveaux derives de quinoleine, quinoxaline et quinazoline er composition pharmaceutiques les contenant |
| US4164570A (en) | 1973-09-24 | 1979-08-14 | David Clough | Stabilized aqueous catecholamine solutions |
| US4201211A (en) | 1977-07-12 | 1980-05-06 | Alza Corporation | Therapeutic system for administering clonidine transdermally |
| US4285967A (en) | 1978-06-30 | 1981-08-25 | Estee Lauder Inc. | Cosmetic preparation for reducing redness of blemishes |
| US4256763A (en) | 1978-09-19 | 1981-03-17 | Mchugh John E | Treatment of herpes simplex infections and acne |
| US5166331A (en) | 1983-10-10 | 1992-11-24 | Fidia, S.P.A. | Hyaluronics acid fractions, methods for the preparation thereof, and pharmaceutical compositions containing same |
| IL92351A (en) | 1988-11-29 | 1994-02-27 | Allergan Inc Irvine | Aqueous opthalmic solutions containing stabilized chlorine dioxide and an inorganic salt |
| FR2648709A1 (fr) | 1989-06-23 | 1990-12-28 | Boehringer Ingelheim France | Nouvelle utilisation de derives de 1-phenyl-2-aminoethanol en tant que moyens cicatrisants |
| US5326763A (en) | 1989-10-12 | 1994-07-05 | Allergan, Inc. | Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives |
| US5204347A (en) | 1989-10-12 | 1993-04-20 | Allergan, Inc. | Methods for using (2-imidazolin-2-ylamino) tetrahydroquinoxalines |
| US5198442A (en) | 1989-10-12 | 1993-03-30 | Allergan, Inc. | (2-imidazolin-2-ylamino) quinoxaline derivatives and methods for using same |
| US5112822A (en) | 1989-10-12 | 1992-05-12 | Allergan, Inc. | (2-imidazolin-2-ylamino) quinoxaline derivatives and methods for using same |
| US5077292A (en) | 1989-10-12 | 1991-12-31 | Allergan, Inc. | (2-imidazolin-2-ylamino) tetrahydroquinoxalines and methods for using same |
| US5021416A (en) | 1989-10-31 | 1991-06-04 | Allergan, Inc. | Method for using (2-imidazolin-2-ylamino) quinoxalines to reduce or maintain intraocular pressure |
| US5237072A (en) | 1990-02-06 | 1993-08-17 | Allergan, Inc. | Method for producing amino-2-imidazoline derivatives |
| US5130441A (en) | 1990-02-06 | 1992-07-14 | Allergan, Inc. | Method for producing amino-2-imidazoline derivatives |
| US5721237A (en) | 1991-05-10 | 1998-02-24 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties |
| US5736165A (en) | 1993-05-25 | 1998-04-07 | Allergan | In-the-eye use of chlorine dioxide-containing compositions |
| JP3683908B2 (ja) | 1993-10-13 | 2005-08-17 | アラーガン、インコーポレイテッド | （２−イミダゾリン−２−イルアミノ）キノキサリン誘導体の使用方法 |
| US6323204B1 (en) | 1993-10-13 | 2001-11-27 | Allergan | Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives |
| US6117871A (en) | 1993-12-17 | 2000-09-12 | The Procter & Gamble Company | 6-(2-imidazolinylamino)quinoxaline compounds useful as alpha-2 adrenoceptor agonists |
| WO1996013267A2 (en) | 1994-10-27 | 1996-05-09 | Allergan | Combinations of prostaglandins and brimonidine or derivatives thereof for the treatment of glaucoma |
| US5688810A (en) | 1994-12-22 | 1997-11-18 | Ligand Pharmaceuticals Incorporated | Steroid receptor modulator compounds and methods |
| WO1996025163A1 (en) | 1995-02-14 | 1996-08-22 | Board Of Supervisors Or Louisiana State Universityof Agricultural And Mechanical College Through Itsmedical Center | Treatment of herpes simplex viruses |
| US6194415B1 (en) | 1995-06-28 | 2001-02-27 | Allergan Sales, Inc. | Method of using (2-imidazolin-2-ylamino) quinoxoalines in treating neural injury |
| US5720962A (en) | 1995-10-04 | 1998-02-24 | Au Pharmaceuticals, Inc. | Analgesic lotion for hemorrhoids and method of making such lotion |
| US6441047B2 (en) | 1995-11-17 | 2002-08-27 | Alcon Manufacturing Ltd.. | Combination therapy for treating glaucoma |
| US5753637A (en) | 1996-10-09 | 1998-05-19 | Ideal Ideas, Inc. | Method of treating acne conditions |
| US5916574A (en) | 1996-10-09 | 1999-06-29 | Ideal Ideas, Inc. | Method of treating natural poison skin conditions |
| WO1998036730A2 (de) | 1997-02-21 | 1998-08-27 | Beiersdorf Ag | Zubereitungen für die behandlung von rosacea |
| US6159944A (en) | 1998-02-27 | 2000-12-12 | Synchroneuron, Llc | Method for treating painful conditions of the anal region and compositions therefor |
| CN1663559B (zh) | 1998-03-11 | 2010-10-06 | 株式会社创研 | 皮肤健全剂 |
| US6432934B1 (en) | 1998-08-06 | 2002-08-13 | Advanced Vision Research | Methods and compositions for topical treatment of eye surface inflammation and related dry eye disease |
| US20030087962A1 (en) | 1998-10-20 | 2003-05-08 | Omeros Corporation | Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation |
| US20020197300A1 (en) | 1999-02-22 | 2002-12-26 | Schultz Clyde L. | Drug delivery system for anti-glaucomatous medication |
| AU5331200A (en) | 1999-06-11 | 2001-01-02 | Ohio State University Research Foundation, The | Methods and compositions for treating raynaud's phenomenon and scleroderma |
| US6147102A (en) | 1999-10-26 | 2000-11-14 | Curatek Pharmaceuticals Holding, Inc. | Clonidine preparations |
| US20030077301A1 (en) | 1999-12-16 | 2003-04-24 | Maibach Howard I. | Topical pharmaceutical composition for the treatment of inflammatory dermatoses |
| US6294553B1 (en) | 2000-02-15 | 2001-09-25 | Allergan Sales, Inc. | Method for treating ocular pain |
| US6284765B1 (en) | 2000-04-27 | 2001-09-04 | The University Of North Texas Health Science Center At Fort Worth | (+) naloxone and epinephrine combination therapy |
| US6444681B1 (en) | 2000-06-09 | 2002-09-03 | The Ohio State University Research Foundation | Methods and compositions for treating Raynaud's Phenomenon and scleroderma |
| US6468989B1 (en) | 2000-07-13 | 2002-10-22 | Dow Pharmaceutical Sciences | Gel compositions containing metronidazole |
| US6387383B1 (en) | 2000-08-03 | 2002-05-14 | Dow Pharmaceutical Sciences | Topical low-viscosity gel composition |
| US7211267B2 (en) | 2001-04-05 | 2007-05-01 | Collagenex Pharmaceuticals, Inc. | Methods of treating acne |
| US20020198209A1 (en) | 2001-05-03 | 2002-12-26 | Allergan Sales Inc. | Compositions having enhanced pharmacokinetic characteristics |
| AU2002256471B2 (en) | 2001-05-03 | 2007-05-24 | Allergan, Inc. | Compositions having enhanced pharmacokinetic characteristics |
| US6680062B2 (en) | 2001-10-05 | 2004-01-20 | Color Access, Inc. | Anti-irritating rosacea treatment |
| US20040266776A1 (en) | 2003-06-25 | 2004-12-30 | Gil Daniel W. | Methods of preventing and reducing the severity of stress-associated conditions |
| US7345065B2 (en) | 2002-05-21 | 2008-03-18 | Allergan, Inc. | Methods and compositions for alleviating pain |
| US20040092482A1 (en) | 2002-11-07 | 2004-05-13 | Gupta Shyam K. | Hydroxy acids based delivery systems for skin resurfacing and anti-aging compositions |
| US20040156873A1 (en) | 2003-02-10 | 2004-08-12 | Gupta Shyam K. | Topically Bioavailable Acne and Rosacea Treatment Compositions |
| US20040220259A1 (en) | 2003-04-04 | 2004-11-04 | Yu Ruey J. | Topical treatment of dermatological disorders associated with reactive or dilated blood vessels |
| AU2004241107A1 (en) | 2003-05-15 | 2004-12-02 | Cutanix Corporation | Compositions containing a combination of a pharmaceutical agent or a cosmetic agent and an oxy group-bearing aromatic aldehyde |
| US7439241B2 (en) | 2003-05-27 | 2008-10-21 | Galderma Laboratories, Inc. | Compounds, formulations, and methods for treating or preventing rosacea |
| US20050059664A1 (en) | 2003-09-12 | 2005-03-17 | Allergan, Inc. | Novel methods for identifying improved, non-sedating alpha-2 agonists |
| US7141597B2 (en) * | 2003-09-12 | 2006-11-28 | Allergan, Inc. | Nonsedating α-2 agonists |
| US20050020600A1 (en) | 2003-07-23 | 2005-01-27 | Scherer Warren J. | Methods of treating cutaneous flushing using selective alpha-2-adrenergic receptor agonists |
| US20050059744A1 (en) | 2003-09-12 | 2005-03-17 | Allergan, Inc. | Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions |
| KR20060126448A (ko) * | 2003-09-12 | 2006-12-07 | 알러간, 인코포레이티드 | 통증 및 다른 알파 2 아드레날린 매개 증상을 치료하기위한 방법 및 조성물 |
| US7285544B2 (en) * | 2003-11-18 | 2007-10-23 | Bernstein Eric F | Use of nitroxides in treating skin disease |
| US7239705B2 (en) | 2003-12-10 | 2007-07-03 | Motorola Inc. | Apparatus and method for broadcast services transmission and reception |
| WO2005070465A2 (en) | 2004-01-14 | 2005-08-04 | Gilead Sciences, Inc. | Lipid-based dispersions useful for drug delivery |
| US7812049B2 (en) | 2004-01-22 | 2010-10-12 | Vicept Therapeutics, Inc. | Method and therapeutic/cosmetic topical compositions for the treatment of rosacea and skin erythema using α1-adrenoceptor agonists |
| DK1761266T3 (da) * | 2004-05-25 | 2013-08-05 | Galderma Pharma Sa | Forbindelser, formuleringer og fremgangsmåder til at behandle eller forebygge inflammatoriske hudsygdomme |
| CA2593537A1 (en) * | 2005-01-12 | 2006-07-20 | S.U.L.V.E. Ltd. | Methods and pharmaceutical compositions useful for treating psoriasis |
| US20070082070A1 (en) | 2005-10-11 | 2007-04-12 | Stookey Evangeline L | Treating skin disorders |
| WO2007103687A2 (en) * | 2006-03-01 | 2007-09-13 | Tristrata, Inc. | Composition and method for topical treatment of tar-responsive dermatological disorders |
| US20090061020A1 (en) * | 2007-08-31 | 2009-03-05 | Theobald Klaus P | Brimonidine Compositions for Treating Erythema |
| CN101951903A (zh) * | 2008-02-15 | 2011-01-19 | 骨治疗公司 | 用于治疗或预防骨关节疾病的药物组合物 |
| EP2090307A1 (en) | 2008-02-15 | 2009-08-19 | Bone Therapeutics | Pharmaceutical composition for the treatment or prevention of osteoarticular diseases |
| ES2658354T3 (es) * | 2008-02-15 | 2018-03-09 | Bone Therapeutics S.A. | Composición farmacéutica para el uso en el tratamiento y/o la prevención de enfermedades osteoarticulares |
| US8394800B2 (en) | 2009-11-19 | 2013-03-12 | Galderma Laboratories, L.P. | Method for treating psoriasis |
| US8053427B1 (en) | 2010-10-21 | 2011-11-08 | Galderma R&D SNC | Brimonidine gel composition |
-
2009
- 2009-11-19 US US12/621,942 patent/US8394800B2/en not_active Expired - Fee Related
-
2010
- 2010-11-18 RU RU2012125249/15A patent/RU2538729C2/ru not_active IP Right Cessation
- 2010-11-18 JP JP2012540047A patent/JP5680660B2/ja not_active Expired - Fee Related
- 2010-11-18 CA CA2781112A patent/CA2781112C/en not_active Expired - Fee Related
- 2010-11-18 NZ NZ600333A patent/NZ600333A/en not_active IP Right Cessation
- 2010-11-18 AU AU2010332233A patent/AU2010332233C1/en not_active Ceased
- 2010-11-18 KR KR1020137021672A patent/KR20130106439A/ko not_active Withdrawn
- 2010-11-18 CN CN201080051989.9A patent/CN102844025B/zh not_active Expired - Fee Related
- 2010-11-18 KR KR1020127015875A patent/KR101374907B1/ko not_active Expired - Fee Related
- 2010-11-18 MX MX2012005790A patent/MX2012005790A/es active IP Right Grant
- 2010-11-18 WO PCT/US2010/057184 patent/WO2011075267A1/en not_active Ceased
- 2010-11-18 EP EP10779906.6A patent/EP2501373B1/en not_active Not-in-force
- 2010-11-18 BR BR112012012131A patent/BR112012012131A2/pt not_active IP Right Cessation
- 2010-11-18 ES ES10779906.6T patent/ES2532527T3/es active Active
-
2013
- 2013-03-05 US US13/785,802 patent/US9072739B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013511534A5 (cg-RX-API-DMAC7.html) | ||
| ES2368974T3 (es) | Preparación que contiene osmolitos para uso en caso de membranas mucosas secas. | |
| JP2668800B2 (ja) | 皮膚疾患の局所治療 | |
| US20120264818A1 (en) | Topical Compositions with Cannabis Extracts | |
| JP2010537988A5 (cg-RX-API-DMAC7.html) | ||
| US20130072532A1 (en) | Topical transdermal dexmedetomidine compositions and methods of use thereof | |
| JP2011529038A5 (cg-RX-API-DMAC7.html) | ||
| JP2009280627A5 (cg-RX-API-DMAC7.html) | ||
| US11382900B2 (en) | Composition for preventing or treating sleep disorders | |
| EP2056848A2 (en) | Use of extracts for the treatment of viral disorders | |
| WO2009053741A3 (en) | Novel formulation | |
| US20200093785A1 (en) | Skin care compositions and methods | |
| US20130274321A1 (en) | Topical Compositions with Cannabis Extracts | |
| US20190105335A1 (en) | Di-isopropyl-phosphinoyl-alkanes as topical agents for the treatment of sensory discomfort | |
| JP2016517882A5 (cg-RX-API-DMAC7.html) | ||
| Bhanusali et al. | Treatment outcomes for tinea capitis in a skin of color population | |
| CN102764256A (zh) | 一种治疗痤疮的药膏 | |
| JP5179352B2 (ja) | ウイルス性障害の治療のためのカルコン類の使用 | |
| ES2551614T3 (es) | Uso de alcoholes pegilados para el tratamiento de la queratosis actínica | |
| AU2024276277A1 (en) | Pharmaceutical composition | |
| WO2005037275A1 (en) | Topical compositions comprising telmesteine for treating dermatological disorders | |
| JPWO2019002421A5 (cg-RX-API-DMAC7.html) | ||
| CN103458928A (zh) | (r)-1,2-丙二醇用作治疗性冷却剂组合物中的溶剂 | |
| RU2011121659A (ru) | Депигментирующие местные композиции и их применение | |
| ITUB20159582A1 (it) | Composizione, per uso topico, utile per la prevenzione di disturbi di tipo infiammatorio e/o infettivo delle mucose. |